Загрузка...
Next generation chimeric antigen receptor T cells: safety strategies to overcome toxicity
Chimeric antigen receptor T (CAR-T) cell therapy is an emerging and effective cancer immunotherapy. Especially in hematological malignancies, CAR-T cells have achieved exciting results. Two Anti-CD19 CAR-T therapies have been approved for the treatment of CD19-positive leukemia or lymphoma. However,...
Сохранить в:
| Опубликовано в: : | Mol Cancer |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6701025/ https://ncbi.nlm.nih.gov/pubmed/31429760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-019-1057-4 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|